App aims to boost cancer patients' well-being at home

NCT ID NCT06379880

Completed Symptom relief Sponsor: Centre Paul Strauss Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed trial tested a web-based remote monitoring platform called CONTINUUM+ CONNECT in 411 adults with metastatic breast, lung, colorectal, or prostate cancer. Patients used the platform to report symptoms and receive alerts, aiming to improve their physical health and quality of life compared to standard care. The study measured changes in quality-of-life scores after 3 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CONTINUUM+ CONNECT remote monitoring platform (digital device)
What this could lead to: If successful, this could show that remote monitoring helps cancer patients feel better and manage symptoms at home.
What could go wrong: This is a completed study, but it only measures quality of life over 3 months, not survival or cure. Results may not apply to all cancer types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast carcinoma breast neoplasm colorectal cancer colorectal neoplasm lung cancer lung carcinoma lung neoplasm metastatic prostate carcinoma Neoplasm Metastasis prostate cancer prostate neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST NEOPLASMS COLORECTAL NEOPLASMS LUNG NEOPLASMS PROSTATIC NEOPLASMS

Contacts and locations

Locations

CHU de Saint-Etienne

Saint-Priest-en-Jarez, 42270, France
Centre Hospitalier de Morlaix

Morlaix, 29600, France
Centre Paul Strauss

Strasbourg, 67033, France
Centre d'oncologie de Gentilly

Nancy, 54100, France
Chu Dupuytren

Limoges, 87042, France
Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France
Hôpitla privé des Côtes d'Armor - Centre CARIO-HPCA

Plérin, 22190, France
Institut Jean Godinot

Reims, 51100, France
Institut de Cancerologie de Lorraine

Vandœuvre-lès-Nancy, De, 54519, France
Polyclinique de Blois

Blois, 41260, France
Pôle Santé République

Clermont-Ferrand, 63000, France
Sainte-Catherine, Institut du Cancer Avignon-Provence

Avignon, 84918, France
centre Georges François Leclerc

Dijon, 21079, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.